Table 1

Patients and bereaved family characteristics

ILDLung cancerP value
Total (n)n (%)Total (n)n (%)
Patients177184
Age, years76.0 (8.3)74.9 (9.7)0.24
Sex0.40
 Male137 (77.4)135 (73.4)
 Female40 (22.6)49 (26.6)
Institution<0.001
 Seirei Mikatahara Hospital75 (42.4)115 (62.5)
 Seirei Hamamatsu Hospital37 (20.9)19 (10.3)
 Hamamatsu University Hospital33 (18.6)18 (9.8)
 Iwata City Hospital32 (18.1)32 (17.4)
LTOT, yes92 (52.0)29 (15.8)<0.001
Type of disease
 IPF78 (44.1)Adenocarcinoma93 (50.8)
 Non-IPF IIP58 (32.8)Squamous cell carcinoma35 (19.1)
 CTD-IP36 (20.3)Small cell carcinoma25 (13.7)
 CHP3 (1.7)Clinical diagnosis16 (8.7)
 Others2 (1.1)Others14 (7.7)
Cause of death
 Acute exacerbation99 (55.9)Cancer progression180 (97.8)
 Exacerbation of chronic respiratory failure49 (27.7)Treatment-related death2 (1.1)
 Respiratory infection15 (8.5)Infection1 (0.5)
 Others14 (7.9)Others1 (0.5)
Months from diagnosis to death31 (6–61)11 (4–28)<0.001
Bereaved family members8388
Age, years0.53
 >4911 (13.3)10 (11.4)
 50–5915 (18.1)14 (15.9)
 60–6925 (30.1)36 (40.9)
 ≥7032 (38.6)28 (31.8)
Sex0.25
 Male23 (27.7)32 (36.4)
 Female60 (72.3)56 (63.6)
Relationship to patient0.17
 Husband/wife51 (61.4)51 (58.0)
 Child of patient29 (34.9)27 (30.7)
 Others3 (3.6)10 (11.4)
Frequency of visits during the last hospitalisation0.40
 Every day59 (71.1)59 (67.0)
 4–6 days per week8 (9.6)16 (18.2)
 1–3 days per week13 (15.7)11 (12.5)
 No visit3 (3.6)2 (2.3)
  • Categorical variables are expressed as number (percentage).

  • Quantitative variables are expressed as mean (SD) or median (IQR).

  • Fisher’s exact test was used to analyse categorical variables, and Student’s t-test or Mann-Whitney U test was used to analyse quantitative variables as appropriate.

  • CHP, chronic hypersensitivity pneumonitis; CTD-IP, connective tissue disease-related interstitial pneumonia; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; LTOT, long-term oxygen therapy; non-IPF IIP, idiopathic interstitial pneumonia excluding idiopathic pulmonary fibrosis.